HuagongsheHuagongshe Chemistry Print Report · For research reference only
Imatinib → N-(4-Methyl-3-nitro-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Imatinib | HCID 5291 | — |
| Reactant | 4-Methyl-3-nitroaniline | HCID 8390 | — |
| Reactant | Methyl 4-((4-methylpiperazin-1-yl)methyl)benzoate | HCID 782222 | — |
| Product | N-(4-Methyl-3-nitro-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide | HCID 29984087 | — |
Reaction Steps
U.S. Pat. No. 5,521,184 and WO 03/066613 describe synthetic routes for preparing imatinib. One synthetic process, depicted in Scheme 1, involves reacting 4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid methyl ester with 3-nitro-4-methyl-aniline to obtain N-(4-methyl-3-nitrophenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide, which is subsequently reduced to obtain N-(3-amino-4-methyl-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benizamide. The latter is reacted with cyanamide (NH2CN) in a mixture of concentrated hydrochloric acid solution and n-butanol to produce N-(3-guanidino-4-methyl-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide, which is subsequently reacted with 3-dimethylamino-1-pyridin-3-yl-propenone to obtain imatinib.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07550591B2 |
| Source dataset | uspto-grants-2009_06 |
| ORD ID | ord-96dd1705c16f4d86a71c01c50fe83064 |
| Source note | uspto-grants-2009_06 |